KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Total Liabilities (2016 - 2025)

Procter & Gamble (PG) has disclosed Total Liabilities for 17 consecutive years, with $74.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 3.9% to $74.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $74.0 billion, a 3.9% increase, with the full-year FY2025 number at $72.9 billion, up 1.58% from a year prior.
  • Total Liabilities was $74.0 billion for Q4 2025 at Procter & Gamble, roughly flat from $74.0 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $76.5 billion in Q4 2021 to a low of $69.3 billion in Q1 2024.
  • A 5-year average of $72.7 billion and a median of $73.0 billion in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: rose 6.92% in 2021, then decreased 6.94% in 2024.
  • Procter & Gamble's Total Liabilities stood at $76.5 billion in 2021, then dropped by 4.62% to $73.0 billion in 2022, then dropped by 1.52% to $71.9 billion in 2023, then dropped by 0.95% to $71.2 billion in 2024, then grew by 3.9% to $74.0 billion in 2025.
  • Per Business Quant, the three most recent readings for PG's Total Liabilities are $74.0 billion (Q4 2025), $74.0 billion (Q3 2025), and $72.9 billion (Q2 2025).